CSSLdb: Discovery of cancer-specific synthetic lethal interactions based on machine learning and statistic inference

Comput Biol Med. 2024 Mar:170:108066. doi: 10.1016/j.compbiomed.2024.108066. Epub 2024 Jan 29.

Abstract

Synthetic lethality (SL) occurs when the inactivation of two genes results in cell death while the inactivation of either gene alone is non-lethal. SL-based therapy has become a promising anti-cancer treatment option with the increasing researches and applications in clinical practice, while the specific therapeutic opportunities for various cancers have not yet been comprehensively investigated. Herein, we described a computational approach based on machine learning and statistical inference to discover the cancer-specific synthetic lethal interactions. First, Random Forest and One-Class SVM were used to perform cancer unbiased prediction of synthetic lethality. Then, two strategies, including mutual exclusivity and differential expression, were used to screen cancer-specific synthetic lethal interactions, resulting in 14,582 SL gene pairs in 33 cancer types. Finally, we developed a freely available database of CSSLdb (Cancer Specific Synthetic Lethality Database, http://www.tmliang.cn/CSSL/) to present cancer-specific synthetic lethal genetic interactions, which would enrich the relevant research and contribute to underlying therapy strategies based on synthetic lethality.

Keywords: Cancer; Database; Prediction; Synthetic lethality (SL).

MeSH terms

  • Databases, Factual
  • Genes, Lethal
  • Humans
  • Machine Learning
  • Neoplasms* / drug therapy
  • Neoplasms* / genetics